DK0462194T3 - Fibroblastvækstfaktor-(FGF)-baserede stabiliserede sammensætninger - Google Patents

Fibroblastvækstfaktor-(FGF)-baserede stabiliserede sammensætninger

Info

Publication number: DK0462194T3
Authority: DK; Denmark
Prior art keywords: fgf; growth factor; fibroblast growth; stabilized compositions; tissular
Prior art date: 1989-03-09

Application number

DK90904852.2T

Other languages

English (en)

Inventor

Denis Barritault

Jacqueline Jozefonvicz

Faouzi Slaoui

Michele Tardieu

Jean-Pierre Caruelle

Jose Courty

Original Assignee

Therapeutiques Substitutives

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-03-09

Filing date

1990-03-09

Publication date

1994-09-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9379523&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0462194(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1990-03-09 Application filed by Therapeutiques Substitutives filed Critical Therapeutiques Substitutives

1994-09-19 Application granted granted Critical

1994-09-19 Publication of DK0462194T3 publication Critical patent/DK0462194T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Inorganic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Materials For Medical Uses (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Peptides Or Proteins (AREA)

DK90904852.2T 1989-03-09 1990-03-09 Fibroblastvækstfaktor-(FGF)-baserede stabiliserede sammensætninger DK0462194T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR8903086A FR2644066B1 (fr)	1989-03-09	1989-03-09	Compositions stabilisees comprenant des fgfs, leur procede d'obtention et leurs applications therapeutiques, chirurgicales et cosmetologiques

Publications (1)

Publication Number	Publication Date
DK0462194T3 true DK0462194T3 (da)	1994-09-19

Family

ID=9379523

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK90904852.2T DK0462194T3 (da)	1989-03-09	1990-03-09	Fibroblastvækstfaktor-(FGF)-baserede stabiliserede sammensætninger

Country Status (10)

Country	Link
EP (1)	EP0462194B1 (da)
JP (1)	JP3236916B2 (da)
AT (1)	ATE106743T1 (da)
AU (1)	AU5283890A (da)
CA (1)	CA2048638C (da)
DE (1)	DE69009748T2 (da)
DK (1)	DK0462194T3 (da)
ES (1)	ES2057544T3 (da)
FR (1)	FR2644066B1 (da)
WO (1)	WO1990010456A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5202311A (en) *	1988-08-19	1993-04-13	Children's Medical Center Corporation	Stabilized fgf composition
US5482929A (en) *	1991-12-26	1996-01-09	Kaken Pharmaceutical Co., Ltd.	Composition of stabilized fibroblast growth factor
FR2718025B1 (fr) *	1994-03-30	1996-06-21	Paris Val Marne Universite	Médicament et composition pharmaceutique pour le traitement des lésions du système nerveux.
FR2718024B1 (fr) *	1994-03-30	1996-06-21	Paris Val Marne Universite	Médicament et composition pharmaceutique pour le traitement de l'inflammation.
FR2718023B1 (fr) *	1994-03-30	1996-08-14	Paris Val Marne Universite	Médicament et composition pharmaceutique pour le traitement de lésions du tractus digestif.
FR2718026B1 (fr) *	1994-03-30	1997-01-17	Paris Val Marne Universite	Médicament et composition pharmaceutique pour le traitement des muscles.
FR2772382B1 (fr) *	1997-12-11	2000-03-03	Solutions	Derives de dextrane, leur procede de preparation et leurs applications comme medicaments a action biologique specifique
FR2781375A1 (fr) *	1998-07-21	2000-01-28	Denis Barritault	Composition anti-fibrotique contenant des polymeres ou biopolymeres et leurs utilisations
FR2781485B1 (fr)	1998-07-21	2003-08-08	Denis Barritault	Polymeres biocompatibles leur procede de preparation et les compositions les contenant
ATE363292T1 (de)	1998-09-04	2007-06-15	Scios Inc	Hydrogelzusammensetzungen mit kontrollierter freigabe von wachstumsfaktoren
FR2794649B1 (fr)	1999-06-11	2003-04-11	Solutions	Biomateriau a base d'un derive de dextrane insolubilise et d'un facteur de croissance, son procede de preparation et ses applications
FR2794976B1 (fr) *	1999-06-16	2004-05-07	Solutions	Compositions pharmaceutiques a action cicatrisante ou anti-complementaire comprenant un derive de dextrane
HRP20190691T1 (hr)	2008-03-27	2019-07-12	Purdue Research Foundation	Sintetički peptidoglikani koji vezuju kolagen, priprema, i postupci upotrebe
EP3208278B1 (en)	2011-05-24	2018-10-31	Symic IP, LLC	Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
US9200039B2 (en)	2013-03-15	2015-12-01	Symic Ip, Llc	Extracellular matrix-binding synthetic peptidoglycans
US10772931B2 (en)	2014-04-25	2020-09-15	Purdue Research Foundation	Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction
US10792106B2 (en)	2016-10-28	2020-10-06	Covidien Lp	System for calibrating an electromagnetic navigation system
WO2019010484A2 (en)	2017-07-07	2019-01-10	Symic Ip, Llc	SYNTHETIC BIOCONJUGATES
US11596399B2 (en)	2021-06-23	2023-03-07	Covidien Lp	Anvil buttress attachment for surgical stapling apparatus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ235556A (en) *	1986-11-05	1991-06-25	Ethicon Inc	Breast milk substitute containing recombinant human egf

1989
- 1989-03-09 FR FR8903086A patent/FR2644066B1/fr not_active Expired - Fee Related
1990
- 1990-03-09 EP EP90904852A patent/EP0462194B1/fr not_active Expired - Lifetime
- 1990-03-09 DE DE69009748T patent/DE69009748T2/de not_active Expired - Lifetime
- 1990-03-09 DK DK90904852.2T patent/DK0462194T3/da active
- 1990-03-09 JP JP50494990A patent/JP3236916B2/ja not_active Expired - Lifetime
- 1990-03-09 AU AU52838/90A patent/AU5283890A/en not_active Abandoned
- 1990-03-09 CA CA002048638A patent/CA2048638C/en not_active Expired - Lifetime
- 1990-03-09 AT AT90904852T patent/ATE106743T1/de not_active IP Right Cessation
- 1990-03-09 WO PCT/FR1990/000164 patent/WO1990010456A1/fr active IP Right Grant
- 1990-03-09 ES ES90904852T patent/ES2057544T3/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP0462194B1 (fr)	1994-06-08
DE69009748D1 (de)	1994-07-14
AU5283890A (en)	1990-10-09
CA2048638A1 (en)	1990-09-10
JPH04505756A (ja)	1992-10-08
EP0462194A1 (fr)	1991-12-27
DE69009748T2 (de)	1994-09-22
JP3236916B2 (ja)	2001-12-10
ATE106743T1 (de)	1994-06-15
WO1990010456A1 (fr)	1990-09-20
FR2644066B1 (fr)	1994-05-13
ES2057544T3 (es)	1994-10-16
CA2048638C (en)	2002-06-11
FR2644066A1 (fr)	1990-09-14

Publication	Publication Date	Title
DK0462194T3 (da)	1994-09-19	Fibroblastvækstfaktor-(FGF)-baserede stabiliserede sammensætninger
DE3874813D1 (de)	1992-10-29	Zusammensetzung zur behandlung der haut.
EP0202298A4 (en)	1988-07-04	MEDICINE FOR Wounds.
DK1699915T3 (da)	2010-09-13	Anvendelse af erythropoietin til levervævsregenerering
BRPI9908182C1 (pt)	2021-05-25	composições de proteína de matriz para cura de feridas
PT1019040E (pt)	2005-01-31	Inibicao da actividade de p38-quinase por meio de arilureias
EE9700225A (et)	1998-02-16	Meetod diabetes mellituse raviks, kasutades KKF
ATE435030T1 (de)	2009-07-15	Heilung von wunden oder fibrotischen krankheiten unter verwendung von wenigstens einem agens gegen einen wachstumsfaktor
ATE96329T1 (de)	1993-11-15	Topisch anwendbare pharmazeutische zubereitung.
DE69033970D1 (de)	2002-07-18	Huperzin a analoge verbindungen
PT809437E (pt)	2005-05-31	Tiois para promover crescimento de celulas progenitoras hematopoieticas
IL126235A (en)	2003-02-12	Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
DE60035133D1 (de)	2007-07-19	Pharmazeutische zusammensetzungen mit wundheilender und anti-komplementärer wirkung die ein dextranderivat enthalten
ATE345809T1 (de)	2006-12-15	Arzneimittelzusammensetzung enthaltend tcf-ii
ES2149347T3 (es)	2000-11-01	Composiciones farmaceuticas de verotoxinas y tratamientos medicos con las mismas.
TR199802706T2 (xx)	1999-05-21	Bir bitki hastal��n�n iyile�tirilmesi i�in y�ntem.
ES2191825T3 (es)	2003-09-16	Sales metalicas de acidos biliares con accion fisiologica y su uso en terapia.
ES8801624A1 (es)	1988-02-16	Procedimiento para preparar disulfuros heterociclicos
ATE127839T1 (de)	1995-09-15	Varianten des gewebeplasminogenaktivators mit vermindertem abbau.
DE69008282D1 (de)	1994-05-26	Kaffeesäure-Derivate, deren Verwendung für medizinische Behandlungen und diese enthaltende pharmazeutische Zusammensetzungen.
UA15363A (uk)	1997-06-30	Засіб для лікуваhhя відкритих пошкоджеhь
UA10281C2 (uk)	2000-11-15	Спосіб отримання речовини для лікування захворювань підшлункової залози